CoreRx Appoints Dan Dobry as Chief Strategy Officer

CoreRx, Inc., a contract development and manufacturing organization (CDMO) providing drug formulation, development, GMP manufacturing and packaging solutions to global pharmaceutical and biopharmaceutical partners, has appointed Dan Dobry as chief strategy officer, reporting to CoreRx’s CEO, Ajay Damani.

Dan brings to CoreRx 25 years of experience as a global CDMO business leader and drug delivery innovator. Early in his career, he contributed to process and formulation development, particle engineering and materials science innovations, resulting in more than 15 patents. Dan’s experience in the pharma services industry, manufacturing science and technology, product development, alliance management and in corporate development will be a valued addition to the CoreRx team. Previously, he held leadership roles in commercial development at Lonza, strategic alliance management at Capsugel, and as the vice president of engineering for Bend Research.  

In his role as chief strategy officer, Dan will oversee CoreRx’s strategy and corporate development functions.

“This is an exciting time for CoreRx, with significant growth occurring across our business,” said Damani. “Dan brings a unique combination of technical background and experience in executive level decision-making and leadership that will strengthen our team.”

From its state-of-the-art, multi-site campus in Clearwater, FL and its early product development center in San Rafael, CA, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale and across a range of dosage forms.